Valo Therapeutics (AgeTech UK) ^Covid-19

Pepti-CRAd peptide coated replicating adenovirus . Is a spin-out company from the IVTLab at the University of Helsinki, Finland. Valo Tx has assembled a uniquely talented team of oncolytic virus and immunotherapy experts, who together with the founding scientist have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.